Metrics from the CPHI Annual Survey suggest that confidence in the global pharma market has risen significantly in the past year.
Announced at CPHI Frankfurt, the CPHI Annual Survey – which features insights from 400 global pharma companies – revealed that global pharma confidence in growth, innovation, and manufacturing quality has reached record highs.The overall CPHI Pharma Index, a collateralized metric of all major ranking categories, has risen by more than 8%, the largest year-on-year gain in the survey’s six year history.
According to the results, the United States remained at the top of the pharma industry rankings, while Germany remained in second and the United Kingdom knocked Japan off the podium; both of these countries posted double-digit growth. Notably, the range of scores continued to decrease this year, which might suggest a narrowing between industry powerhouses and emerging pharma nations.
India had the most significant score change, ranking alongside leading western nations for the first time; the country also retained its high score for growth potential. India also continued to improve in terms of “API Quality”, with a 15% improvement, second only to China’s 25% improvement in this sector. India is now level with both Switzerland and Japan in this category, while China rivals France and Italy.
“These findings are incredibly positive for pharma manufacturers and demonstrate that the industry believes they have made great strides to further improve quality,” said Adam Anderson, executive vice-president, Informa Markets, in an agency press release. “It’s also very encouraging that, as we open CPHI Frankfurt, we see such optimism for pharmaceutical production next year, with the industry bucking wider macroeconomic headwinds. The partnerships established this week at CPHI Frankfurt will be invaluable in helping deliver on this potential and I encourage the industry not only to meet in person, but to also use all the post-event digital partnering tools available.”
Source: CPHI
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
WMFTS’ BioPure to Showcase Single-Use Bioclamp with Refined Manufacturing at INTERPHEX 2025
April 1st 2025With advanced manufacturing, BioPure’s BioClamp connector is manufactured to be 13% lighter than the previous model, resulting in a 26% reduction in carbon dioxide emissions across the full lifecycle of the product.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.